Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Less painful glucose monitor cleared by US FDA:

This article was originally published in Clinica

Executive Summary

TheraSense, of Alameda, California has received FDA clearance for its FreeStyle "virtually pain-free" blood glucose test for diabetics. The test allows people suffering from the condition to obtain a blood sample from sites other than the fingertips, where close proximity of the nerve endings makes repeat testing painful. FreeStyle was developed to improve diabetes management and provides a blood glucose value using a fraction of the blood sample currently required by other products on the market, said the company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel